181 related articles for article (PubMed ID: 172392)
1. Cyclic nucleotide phosphodiesterases in uterine development.
Stancel GM; Thompson WJ; Strada SJ
Mol Cell Endocrinol; 1975 Oct; 3(4):283-95. PubMed ID: 172392
[TBL] [Abstract][Full Text] [Related]
2. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
Gardner EA; Thompson WJ; Strada SJ; Stancel GM
Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
Azhar S; Menon KM
Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
[TBL] [Abstract][Full Text] [Related]
4. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
5. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics.
Pichard AL; Cheung WY
J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086
[TBL] [Abstract][Full Text] [Related]
6. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
Asano T; Hidaka H
Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
[TBL] [Abstract][Full Text] [Related]
7. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
Nagasaka A; Hidaka H
Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
9. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
11. Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
Donnelly TE
Biochim Biophys Acta; 1977 Jan; 480(1):194-203. PubMed ID: 188479
[TBL] [Abstract][Full Text] [Related]
12. Changes in phosphodiesterase activity in the developing rat submandibular gland.
Tanaka S; Shimooka S; Shimomura H
Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
14. Activation of mammalian cyclic AMP phosphodiesterases by trypsin.
Epstein PM; Pledger WJ; Gardner EA; Stancel GM; Thompson WJ; Strada SJ
Biochim Biophys Acta; 1978 Dec; 527(2):442-55. PubMed ID: 215213
[TBL] [Abstract][Full Text] [Related]
15. Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity.
Fanidi A; Ahnadi C; Fayard JM; Pageaux JF; Laugier C
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):571-7. PubMed ID: 1314079
[TBL] [Abstract][Full Text] [Related]
16. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
Bellamy TC; Garthwaite J
Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
[TBL] [Abstract][Full Text] [Related]
17. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
DeRubertis FR; Craven PA
Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide phosphodiesterase in silkworm. Developmental change of cyclic AMP and cyclic GMP phosphodiesterases.
Morishima I
Biochim Biophys Acta; 1975 Sep; 403(1):106-12. PubMed ID: 240422
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cyclic nucleotide phosphodiesterase activity in myometrium from pregnant and spayed rhesus monkeys.
Beatty CH; Bocek RM; Herrington PT
J Reprod Fertil; 1979 Mar; 55(2):391-400. PubMed ID: 220417
[TBL] [Abstract][Full Text] [Related]
20. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
Craven PA; Neidig M; DeRubertis FR
Biochim Biophys Acta; 1983 May; 744(3):265-75. PubMed ID: 6303428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]